Home › Companies › AMICUS THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and AMICUS THERAPEUTICS INC.’s Form 8-K, filed June 5, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 5, 2025: 7 items on AMICUS THERAPEUTICS INC.’s Form 8-K, filed June 5, 2025: 7 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore AMICUS THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are AMICUS THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Michael A. Kelly | 256,542,874 | -- | -- | 5,972,321 | 20,343,283 | 98% | Not verified | — |
| Elect Director: Margaret G. McGlynn | 253,119,576 | -- | -- | 9,395,619 | 20,343,283 | 96% | Not verified | — |
| Elect Director: Michael G. Raab | 159,986,932 | -- | -- | 102,528,263 | 20,343,283 | 61% | Not verified | — |
| Elect Director: Glenn P. Sblendorio | 255,741,822 | -- | -- | 6,773,373 | 20,343,283 | 97% | Not verified | — |
| 2. Approval of the 2025 Equity Incentive Plan | 253,118,014 | 8,908,436 | 488,745 | -- | 20,343,283 | 97% | Not verified | — |
| 3. Ratification of Ernst & Young LLC as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025 | 277,786,618 | 5,006,701 | 65,159 | -- | -- | 98% | Not verified | — |
| 4. Approval, on an advisory basis, of the Company's executive compensation | 255,789,585 | 6,169,769 | 555,841 | -- | 20,343,283 | 98% | Not verified | — |
Source: AMICUS THERAPEUTICS INC., Form 8-K, filed with the SEC on June 5, 2025 — read the filing on EDGAR.
Each item below shows how the 275 asset managers that disclosed a AMICUS THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Glenn P. Sblendorio
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Glenn P. Sblendorio”): 255,741,822 for, 6,773,373 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 78 asset managers below reported 111,924,883 for, 1,424,693 withheld, 60,431 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,825,672 | 0 | 0 | 0 | For |
| BlackRock | 14,260,470 | 0 | 0 | 0 | For |
| Fidelity | 6,929,698 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 3,547,888 | 0 | 0 | 0 | For |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 3,325,232 | 0 | 0 | 162 | For |
| MFS | 3,133,772 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 2,518,083 | 0 | 0 | 0 | For |
| Invesco | 2,178,748 | 0 | 0 | 0 | For |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 1,141,704 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 869,912 | 0 | 0 | 0 | For |
| Equitable | 465,580 | 0 | 0 | 356,529 | Mixed |
| T. Rowe Price | 0 | 0 | 0 | 784,270 | Withhold |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 495,108 | 0 | 0 | 0 | For |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 431,284 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 385,828 | 0 | 0 | 0 | For |
| Northwestern Mutual | 327,828 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Margaret G. McGlynn
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Margaret G. McGlynn”): 253,119,576 for, 9,395,619 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 78 asset managers below reported 111,961,840 for, 1,387,736 withheld, 60,431 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,823,190 | 0 | 0 | 2,482 | For |
| BlackRock | 14,260,470 | 0 | 0 | 0 | For |
| Fidelity | 6,929,698 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 3,547,888 | 0 | 0 | 0 | For |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 3,325,232 | 0 | 0 | 162 | For |
| MFS | 3,133,772 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 2,518,083 | 0 | 0 | 0 | For |
| Invesco | 2,178,748 | 0 | 0 | 0 | For |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 1,141,704 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 869,912 | 0 | 0 | 0 | For |
| Equitable | 465,580 | 0 | 0 | 356,529 | Mixed |
| T. Rowe Price | 0 | 0 | 0 | 784,270 | Withhold |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 495,108 | 0 | 0 | 0 | For |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 431,284 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 385,828 | 0 | 0 | 0 | For |
| Northwestern Mutual | 327,828 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Michael A. Kelly
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael A. Kelly”): 256,542,874 for, 5,972,321 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 78 asset managers below reported 112,059,825 for, 1,350,182 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,825,672 | 0 | 0 | 0 | For |
| BlackRock | 14,260,470 | 0 | 0 | 0 | For |
| Fidelity | 6,929,698 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 3,547,888 | 0 | 0 | 0 | For |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 3,325,394 | 0 | 0 | 0 | For |
| MFS | 3,133,772 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 2,518,083 | 0 | 0 | 0 | For |
| Invesco | 2,178,748 | 0 | 0 | 0 | For |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 1,141,704 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 869,912 | 0 | 0 | 0 | For |
| Equitable | 465,580 | 0 | 0 | 356,529 | Mixed |
| T. Rowe Price | 0 | 0 | 0 | 784,270 | Withhold |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 495,108 | 0 | 0 | 0 | For |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 431,284 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 385,828 | 0 | 0 | 0 | For |
| Northwestern Mutual | 327,828 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Combines 6 wordings of this item as funds reported it.
61% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Michael G. Raab
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael G. Raab”): 159,986,932 for, 102,528,263 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 61% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 78 asset managers below reported 60,092,257 for, 38,010,127 withheld, 15,307,623 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 28,929,211 | 0 | 0 | 20,896,460 | Mixed |
| BlackRock | 0 | 0 | 14,260,470 | 0 | Abstain |
| Fidelity | 6,531,731 | 0 | 0 | 397,967 | Mixed |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 3,547,888 | 0 | 0 | 0 | For |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 11,549 | 0 | 0 | 3,313,845 | Withhold |
| MFS | 0 | 0 | 0 | 3,133,772 | Withhold |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 2,518,083 | Withhold |
| Invesco | 0 | 0 | 0 | 2,178,748 | Withhold |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 0 | 0 | 0 | 1,141,704 | Withhold |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 653,612 | 0 | 0 | 216,300 | Mixed |
| Equitable | 0 | 0 | 0 | 822,109 | Withhold |
| T. Rowe Price | 0 | 0 | 0 | 784,270 | Withhold |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 0 | 0 | 495,108 | Withhold |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 431,284 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 385,828 | 0 | Abstain |
| Northwestern Mutual | 0 | 0 | 0 | 327,828 | Withhold |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Approval of the 2025 Equity Incentive Plan.
AMICUS THERAPEUTICS INC.’s own tally for this item (“2. Approval of the 2025 Equity Incentive Plan”): 253,118,014 for, 8,908,436 against, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 81 asset managers below reported 109,684,479 for, 4,106,709 against, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,825,672 | 0 | 0 | 0 | For |
| BlackRock | 14,260,470 | 0 | 0 | 0 | For |
| Fidelity | 6,929,698 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 0 | 3,547,888 | 0 | 0 | Against |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 3,325,232 | 162 | 0 | 0 | For |
| MFS | 3,133,772 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 2,518,083 | 0 | 0 | 0 | For |
| Invesco | 2,178,748 | 0 | 0 | 0 | For |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 1,141,704 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 518,700 | 351,212 | 0 | 0 | Mixed |
| Equitable | 822,109 | 0 | 0 | 0 | For |
| T. Rowe Price | 784,270 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 495,108 | 0 | 0 | 0 | For |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 431,284 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 385,828 | 0 | 0 | 0 | For |
| Northwestern Mutual | 327,828 | 0 | 0 | 0 | For |
Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.
Combines 9 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Approval, on an advisory basis, the Company's executive compensation.
AMICUS THERAPEUTICS INC.’s own tally for this item (“4. Approval, on an advisory basis, of the Company's executive compensation”): 255,789,585 for, 6,169,769 against, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of AMICUS THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (8 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,825,656 | 16 | 0 | 0 | For |
| BlackRock | 14,260,470 | 0 | 0 | 0 | For |
| Fidelity | 6,929,698 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 3,547,888 | 0 | 0 | 0 | For |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 3,321,544 | 3,850 | 0 | 0 | For |
| MFS | 3,133,772 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 2,518,083 | 0 | 0 | 0 | For |
| Invesco | 2,178,748 | 0 | 0 | 0 | For |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 1,141,704 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 869,912 | 0 | 0 | 0 | For |
| Equitable | 822,109 | 0 | 0 | 0 | For |
| T. Rowe Price | 784,270 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 495,108 | 0 | 0 | 0 | For |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 431,284 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 385,828 | 0 | 0 | 0 | For |
| Northwestern Mutual | 327,828 | 0 | 0 | 0 | For |
Fund voting reports, all 78 managers: 113,278,903 for, 134,434 against, 56,401 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Wellington | 27,739,707 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 20,500,000 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 16,381,751 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13,676,359 | 0 | 0 | 0 | For |
| BlackRock | 11,558,170 | 0 | 0 | 0 | For |
| State Street | 8,868,623 | 8,216 | 0 | 0 | For |
| Redmile Group, LLC | 7,762,757 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 6,807,379 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 6,028,209 | 0 | 0 | 0 | For |
| Citadel | 5,337,109 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 4,034,737 | 0 | 0 | 0 | For |
| American Century | 3,899,100 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3,537,656 | 0 | 0 | 0 | For |
| Nuveen | 3,522,217 | 0 | 0 | 0 | For |
| Janus Henderson | 3,113,021 | 0 | 0 | 0 | For |
| Northern Trust | 2,977,203 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 2,829,626 | 0 | 0 | 0 | For |
| Charles Schwab | 2,518,336 | 0 | 0 | 0 | For |
| DE Shaw | 2,467,109 | 0 | 0 | 0 | For |
| Point72 | 2,457,315 | 0 | 0 | 0 | For |
| Invesco | 2,320,440 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 1,909,362 | 0 | 0 | 0 | For |
| Granite Investment Partners, LLC | 1,818,637 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 1,794,787 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,693,100 | 0 | 0 | 0 | For |
Institutional-manager reports, all 214 managers: 192,190,401 for, 2,556,336 against. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
AMICUS THERAPEUTICS INC.’s own tally for this item (“3. Ratification of Ernst & Young LLC as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025”): 277,786,618 for, 5,006,701 against, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 79 asset managers below reported 113,461,565 for, 133,212 against, 56,401 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,823,190 | 2,482 | 0 | 0 | For |
| BlackRock | 14,260,470 | 0 | 0 | 0 | For |
| Fidelity | 6,929,698 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 3,547,888 | 0 | 0 | 0 | For |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 3,325,232 | 162 | 0 | 0 | For |
| MFS | 3,133,772 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 2,518,083 | 0 | 0 | 0 | For |
| Invesco | 2,178,748 | 0 | 0 | 0 | For |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 1,141,704 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 869,912 | 0 | 0 | 0 | For |
| Equitable | 822,109 | 0 | 0 | 0 | For |
| T. Rowe Price | 784,270 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 495,108 | 0 | 0 | 0 | For |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 431,284 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 385,828 | 0 | 0 | 0 | For |
| Northwestern Mutual | 327,828 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Vanguard | 49,825,672 |
| 2 | BlackRock | 14,260,470 |
| 3 | Fidelity | 6,929,698 |
| 4 | Delaware/Macquarie | 5,033,046 |
| 5 | American Century | 3,547,888 |
| 6 | TIAA | 3,490,010 |
| 7 | State Street | 3,325,394 |
| 8 | MFS | 3,133,772 |
| 9 | WILLIAM BLAIR FUNDS | 3,063,980 |
| 10 | Charles Schwab | 2,518,083 |
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Wellington | 27,739,707 |
| 2 | Avoro Capital Advisors LLC | 20,500,000 |
| 3 | PERCEPTIVE ADVISORS LLC | 16,381,751 |
| 4 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13,676,359 |
| 5 | BlackRock | 11,558,170 |
| 6 | State Street | 8,876,839 |
| 7 | Redmile Group, LLC | 7,762,757 |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 6,807,379 |
| 9 | MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 6,028,209 |
| 10 | Citadel | 5,337,109 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to AMICUS THERAPEUTICS INC. for the 2024-2025 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At AMICUS THERAPEUTICS INC.'s shareholder meeting held June 5, 2025, in the 2024-2025 proxy season, 275 asset managers reported how they voted on 7 ballot items in their SEC Form N-PX filings, covering 2,031 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory basis, the Company's executive compensation. — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AMICUS THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2025.
AMICUS THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.